Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center

Authors

  • Caroline Lopes Department of Pediatrics. Hospital Dona Estefânia. Lisbon.
  • Ana Castro Hematology Unit. Hospital Dona Estefânia. Lisbon.
  • Raquel Maia Hematology Unit. Hospital Dona Estefânia. Lisbon.
  • Sara Batalha Hematology Unit. Hospital Dona Estefânia. Lisbon.
  • Paula Kjöllerström Hematology Unit. Hospital Dona Estefânia. Lisbon.

DOI:

https://doi.org/10.20344/amp.20532

Keywords:

Child, Purpura, Thrombocytopenic, Idiopathic/drug therapy, Receptors, Thrombopoietin, Thrombocytopenia/drug therapy

Abstract

N/a.

Downloads

Download data is not yet available.

References

Chen M, Fang JP, Zhou CX, Li XY, Lin SF, Xu LH. Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia. Hematology. 2021;26:31-6.

Giordano P, Lassandro G, Barone A, Cesaro S, Fotzi I, Giona F, et al. Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Front Med. 2020;7:66.

Cheng X, Fu LL, Ma J, Gu H, Chen Z, Zhao L, et al. Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood Adv. 2021;5:3799-806.

Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, et al. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;386:1649-58.

Palumbo G, Farruggia P, Ramenghi U, Russo G, Borchiellini A, Spinelli M, et al. Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy. Hematology. 2023;28:2210906.

Downloads

Published

2024-04-01

How to Cite

1.
Lopes C, Castro A, Maia R, Batalha S, Kjöllerström P. Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center. Acta Med Port [Internet]. 2024 Apr. 1 [cited 2024 Oct. 13];37(4):294-5. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20532

Issue

Section

Letters to the Editor